资源描述：
《清热利湿汤治疗急性期痛风性关节炎的临床研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。
1、AClinicalStudyofQingrelishitangTreatingAcuteGoutyArthritisSpecia1ity:InternalMedicineofTCMAuthor:DingzhiguoTutor:FuxinliAbstractObjective：ThroughclinicalresearchofQingrelishitangandfutalintreatingacutegoutyarthritis,weexplorethetreatmentofChineseandWesternmedicinemethodandclinicalefficacyofacutegou
2、tyarthritis.Methods：Collect60casesofaccumulatedgoutyarthritis.30casesintreatmentgroup,totreatwithQingrelishitangandfutalin;30casesofcontrolgrouptreatedbycolchicinesandfutalin.Bothsgroupstake10dayscourseoftreatment,Wedealedblooduricacid,erythrocytesedimentationrate,C-reactiveproteinvalue,symptomssco
3、re,adversereactions,andrelapserateforstatisticalanalysis.Results：1.Nosignificantinage,diseasecourse,blooduricacid,erythrocytesedimentationrate,C-reactiveproteinvalueandsymptomsscorebeforetreatment（P>0.05）.2.Intreatmentgroup,symptomsandsignspoints,blooduricacid,erythrocytesedimentationrateandC-react
4、iveproteinvalueswerestatisticallysignificant（P<0.05）.3.Incontrolgroup,symptomsandsignspoints,erythrocytesedimentationrateandC-reactiveproteinvaluewerestatisticallysignificant（P<0.05）,withnosignificanceinblooduricacid（P>0.05）.4.Symptomsandsignspoints,anderythrocytesedimentationratewerestatisticallys
5、ignificantinbothgroup（P<0.05）,withnosignificanceinC-reactiveproteinvaluesandblooduricacid,.5.Totaleffectiveratedifferencewerestatisticallysignificant,inbothgroup（P>0.05）.6.Rrecurrencerateofsymptomswithin3monthswerestatisticallysignificant,inbothgroup（P<0.05）;withnosignificanceinremissiontime（P>0.05
6、）.7.Differencesinadversereactionsrateshowednosignificance,inbothgroup（P>0.05）.Conclusion：Qingrelishitangandfutalincanalleviateacutegoutyarthritisjointpain，jointswellingandotherlimitedsymptomseffectively,lowerblooduricacid,erythrocytesedimentationrateandC-reactiveprotein,recurrencerate,itcanbeworthy
7、ofclinicalapplication.KeyWordsgoutyarthritis;acute;qingrelishitang;futalin;clinicalresearch目录引言...............................................................................................................
